NCT00678288 2014-12-11A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.BayerPhase 2 Terminated16 enrolled 6 charts